Joyce L. Ross

2.1k total citations · 1 hit paper
9 papers, 1.0k citations indexed

About

Joyce L. Ross is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Joyce L. Ross has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Economics and Econometrics. Recurrent topics in Joyce L. Ross's work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Joyce L. Ross is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Joyce L. Ross collaborates with scholars based in United States. Joyce L. Ross's co-authors include Daniel J. Rader, Paul Ziajka, Anne C. Goldberg, Jennifer G. Robinson, William C. Cromwell, Christie M. Ballantyne, Peter P. Tóth, Paul N. Hopkins, Mary P. McGowan and Sarah D. de Ferranti and has published in prestigious journals such as JAMA, The American Journal of Cardiology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Joyce L. Ross

9 papers receiving 969 citations

Hit Papers

Familial Hypercholesterolemia: Screening, diagnosis and m... 2011 2026 2016 2021 2011 100 200 300 400

Peers

Joyce L. Ross
Nicholas Marston United States
Lance Sullenberger United States
Mahmoud Barbir United Kingdom
Renato Quispe United States
Lina Kang China
Joel Kahn United States
Howard M. Monroe United States
Walter Massón Argentina
Nicholas Marston United States
Joyce L. Ross
Citations per year, relative to Joyce L. Ross Joyce L. Ross (= 1×) peers Nicholas Marston

Countries citing papers authored by Joyce L. Ross

Since Specialization
Citations

This map shows the geographic impact of Joyce L. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce L. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce L. Ross more than expected).

Fields of papers citing papers by Joyce L. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce L. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce L. Ross. The network helps show where Joyce L. Ross may publish in the future.

Co-authorship network of co-authors of Joyce L. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce L. Ross. A scholar is included among the top collaborators of Joyce L. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce L. Ross. Joyce L. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Orringer, Carl E., Terry A. Jacobson, Joseph J. Saseen, et al.. (2017). Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association. Journal of clinical lipidology. 11(4). 880–890. 80 indexed citations
2.
Ross, Joyce L.. (2016). Statins in the Management of Pediatric Dyslipidemia. Journal of Pediatric Nursing. 31(6). 723–735. 10 indexed citations
3.
Brown, W. Virgil, Dean A. Bramlet, Joyce L. Ross, & James Underberg. (2016). JCL roundtable: Risk evaluation and mitigation strategy. Journal of clinical lipidology. 10(6). 1288–1296. 5 indexed citations
4.
Marbach, Jeffrey A., et al.. (2014). Novel Treatments for Familial Hypercholesterolemia: Pharmacogenetics at Work. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(9). 961–972. 7 indexed citations
5.
Goldberg, Anne C., Paul N. Hopkins, Peter P. Tóth, et al.. (2011). Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients. Journal of clinical lipidology. 5(3). 133–140. 465 indexed citations breakdown →
6.
Goldberg, Anne C., Jennifer G. Robinson, William C. Cromwell, Joyce L. Ross, & Paul Ziajka. (2011). Future issues, public policy, and public awareness of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of clinical lipidology. 5(3). S46–S51. 21 indexed citations
7.
Ross, Joyce L., et al.. (2003). Identification and Management of Vascular Risk: Beyond Low Density Lipoprotein Cholesterol. AAOHN Journal. 51(12). 521–531. 2 indexed citations
8.
Wolfe, Megan L., Joyce L. Ross, Emile R. Mohler, et al.. (2001). Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia. The American Journal of Cardiology. 87(4). 476–479. 79 indexed citations
9.
Gorelick, Philip B., Ralph L. Sacco, Don B. Smith, et al.. (1999). Prevention of a First Stroke. JAMA. 281(12). 1112–1112. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026